Kunming Longjin Pharmaceutical Co.,Ltd. Posted 18.4 Million Yuan Net Loss in First Half of 2023

Kunming Longjin Pharmaceutical Co.,Ltd. (昆明龙津药业股份有限公司) (002750.SZ) reported a net loss of 18.4 million yuan in the first half of 2023, widening 311.8% year-on-year.

Meanwhile, the company posted 43.6 million yuan in revenue, down 44.1% year-on-year.

At the end of the reporting period, it had 695.8 million yuan in total assets and 102.8 million yuan in total liabilities, with a liability-to-asset ratio of 14.8%.